Results from VENTURE Phase 2 Study of Subcutaneous VK2735 in Obese Patients and Phase 1 Trial of Oral VK2735 in Healthy Subjects to be Presented One presentation will summarize results from the ...

PASADENA, Calif.--(BUSINESS WIRE)-- Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that preclinical data on ARO-INHBE, an investigational RNAi-based medicine for the treatment of ...

Obesity now affects more than one in five children in the United States, and while there are effective, recommended interventions, availability is limited for most children. In two new studies, Yale ...

BOSTON--(BUSINESS WIRE)--Today, Form Health, the leading provider of science-based obesity care in the United States, announced a new program to prevent progression from overweight to obesity.

SAN DIEGO, Nov. 6, 2025 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and ...

Rhythm Pharmaceuticals announced significant data regarding their treatments for acquired hypothalamic obesity during the Endocrine Society’s Annual Meeting. Presentations highlighted the promising ...

In many rural Arkansas counties, access to healthy food, nutrition education and safe places for physical activity are limited, contributing to higher rates of obesity. To help improve these ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...

"Most effective therapies" underutilized, say authors, but oncologist cites lack of qualit ...